{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:49:44Z","timestamp":1792093784725,"version":"4.4.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herz"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00059-026-05391-9","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:30:04Z","timestamp":1790242204000},"page":"389-398","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Vorhofflimmern","Atrial fibrillation"],"prefix":"10.1007","volume":"51","author":[{"given":"Laura","family":"Fischbach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Willems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arian","family":"Sultan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"issue":"6","key":"5391_CR1","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41569-022-00820-8","volume":"20","author":"AD Elliott","year":"2023","unstructured":"Elliott\u00a0AD, Middeldorp\u00a0ME, Van Gelder\u00a0IC et\u00a0al (2023) Epidemiology and modifiable risk factors for atrial fibrillation. Nat Rev Cardiol 20(6):404\u2013417","journal-title":"Nat Rev Cardiol"},{"issue":"5","key":"5391_CR2","doi-asserted-by":"crossref","first-page":"437","DOI":"10.7861\/clinmed.2023-23.5.Cardio2","volume":"23","author":"K Saleh","year":"2023","unstructured":"Saleh\u00a0K, Haldar\u00a0S (2023) Atrial fibrillation: a\u00a0contemporary update. Clin Med (Lond) 23(5):437\u2013441","journal-title":"Clin Med (Lond)"},{"key":"5391_CR3","volume-title":"H\u00e4ufigkeit und Kosten von isch\u00e4mischen Schlaganf\u00e4llen und Vorhofflimmern in Deutschland (GKV) unter Ber\u00fccksichtigung von Versorgungsaspekten","author":"A H\u00f6er","year":"2023","unstructured":"H\u00f6er\u00a0A, Schiffhorst\u00a0G, Berkemeier\u00a0F (2023) H\u00e4ufigkeit und Kosten von isch\u00e4mischen Schlaganf\u00e4llen und Vorhofflimmern in Deutschland (GKV) unter Ber\u00fccksichtigung von Versorgungsaspekten. IGES Institut, Berlin"},{"issue":"5","key":"5391_CR4","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks\u00a0G, Potpara\u00a0T, Dagres\u00a0N et\u00a0al (2021) 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J 42(5):373\u2013498","journal-title":"Eur Heart J"},{"key":"5391_CR5","unstructured":"Eckardt L, Willems S (2025) Deutsche Gesellschaft f\u00fcr Kardiologie: S3-Leitlinie Vorhofflimmern \u2013 Version 1. AWMF-Leitlinienregister Nr. 019-014. AWMF-LeitlinieVorhofflimmernPDF. Zugegriffen: 24. Mai 2026"},{"issue":"1 Pt C","key":"5391_CR6","volume":"49","author":"S Elsheikh","year":"2024","unstructured":"Elsheikh\u00a0S, Hill\u00a0A, Irving\u00a0G et\u00a0al (2024) Atrial fibrillation and stroke: State-of-the-art and future directions. Curr Probl Cardiol 49(1 Pt C):102181","journal-title":"Curr Probl Cardiol"},{"issue":"14","key":"5391_CR7","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1177\/2047487317715769","volume":"24","author":"V Ruddox","year":"2017","unstructured":"Ruddox\u00a0V, Sandven\u00a0I, Munkhaugen\u00a0J et\u00a0al (2017) Atrial fibrillation and the risk for myocardial infarction, all-cause mortality and heart failure: A systematic review and meta-analysis. Eur J Prev Cardiol 24(14):1555\u20131566","journal-title":"Eur J Prev Cardiol"},{"issue":"3","key":"5391_CR8","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1161\/STROKEAHA.115.012004","volume":"47","author":"H Kamel","year":"2016","unstructured":"Kamel\u00a0H, Okin\u00a0PM, Elkind\u00a0MS et\u00a0al (2016) Atrial Fibrillation and Mechanisms of Stroke: Time for a New Model. Stroke 47(3):895\u2013900","journal-title":"Stroke"},{"issue":"2","key":"5391_CR9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","volume":"137","author":"GY Lip","year":"2010","unstructured":"Lip\u00a0GY, Nieuwlaat\u00a0R, Pisters\u00a0R et\u00a0al (2010) Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 137(2):263\u2013272","journal-title":"Chest"},{"issue":"12","key":"5391_CR10","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","volume":"361","author":"SJ Connolly","year":"2009","unstructured":"Connolly\u00a0SJ, Ezekowitz\u00a0MD, Yusuf\u00a0S et\u00a0al (2009) Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 361(12):1139\u20131151","journal-title":"N Engl J Med"},{"issue":"10","key":"5391_CR11","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","volume":"365","author":"MR Patel","year":"2011","unstructured":"Patel\u00a0MR, Mahaffey\u00a0KW, Garg\u00a0J et\u00a0al (2011) Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 365(10):883\u2013891","journal-title":"N Engl J Med"},{"issue":"11","key":"5391_CR12","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","volume":"365","author":"CB Granger","year":"2011","unstructured":"Granger\u00a0CB, Alexander\u00a0JH, McMurray\u00a0JJ et\u00a0al (2011) Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 365(11):981\u2013992","journal-title":"N Engl J Med"},{"issue":"22","key":"5391_CR13","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","volume":"369","author":"RP Giugliano","year":"2013","unstructured":"Giugliano\u00a0RP, Ruff\u00a0CT, Braunwald\u00a0E et\u00a0al (2013) Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med 369(22):2093\u20132104","journal-title":"N Engl J Med"},{"issue":"20","key":"5391_CR14","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.jacc.2015.03.002","volume":"65","author":"RK Pathak","year":"2015","unstructured":"Pathak\u00a0RK, Middeldorp\u00a0ME, Meredith\u00a0M et\u00a0al (2015) Long-Term Effect of Goal-Directed Weight Management in an Atrial Fibrillation Cohort: A Long-Term Follow-Up Study (LEGACY). J\u00a0Am Coll Cardiol 65(20):2159\u20132169","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"5391_CR15","volume":"70","author":"P Kirchhof","year":"2017","unstructured":"Kirchhof\u00a0P, Benussi\u00a0S, Kotecha\u00a0D et\u00a0al (2017) 2016 ESC Guidelines for the Management of Atrial Fibrillation Developed in Collaboration With EACTS. Rev Esp Cardiol (Engl Ed) 70(1):50","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"issue":"8","key":"5391_CR16","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jacc.2009.11.040","volume":"55","author":"CB de Vos","year":"2010","unstructured":"de Vos\u00a0CB, Pisters\u00a0R, Nieuwlaat\u00a0R et\u00a0al (2010) Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis. J\u00a0Am Coll Cardiol 55(8):725\u2013731","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"5391_CR17","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJMoa2019422","volume":"383","author":"P Kirchhof","year":"2020","unstructured":"Kirchhof\u00a0P, Camm\u00a0AJ, Goette\u00a0A et\u00a0al (2020) Early Rhythm-Control Therapy in Patients with Atrial Fibrillation. N Engl J Med 383(14):1305\u20131316","journal-title":"N Engl J Med"},{"issue":"4","key":"5391_CR18","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/j.1552-4604.1984.tb01822.x","volume":"24","author":"EM Vaughan Williams","year":"1984","unstructured":"Vaughan Williams\u00a0EM (1984) A classification of antiarrhythmic actions reassessed after a decade of new drugs. J\u00a0Clin Pharmacol 24(4):129\u2013147","journal-title":"J Clin Pharmacol"},{"issue":"2","key":"5391_CR19","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1056\/NEJMoa2212540","volume":"388","author":"JG Andrade","year":"2023","unstructured":"Andrade\u00a0JG, Deyell\u00a0MW, Macle\u00a0L et\u00a0al (2023) Progression of Atrial Fibrillation after Cryoablation or Drug Therapy. N Engl J Med 388(2):105\u2013116","journal-title":"N Engl J Med"},{"issue":"10","key":"5391_CR20","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1056\/NEJMra032426","volume":"350","author":"DM Roden","year":"2004","unstructured":"Roden\u00a0DM (2004) Drug-induced prolongation of the QT interval. N Engl J Med 350(10):1013\u20131022","journal-title":"N Engl J Med"},{"issue":"11","key":"5391_CR21","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1001\/jama.298.11.1312","volume":"298","author":"P Vassallo","year":"2007","unstructured":"Vassallo\u00a0P, Trohman\u00a0RG (2007) Prescribing amiodarone: an evidence-based review of clinical indications. JAMA 298(11):1312\u20131322","journal-title":"JAMA"},{"issue":"12","key":"5391_CR22","volume":"12","author":"CE Budin","year":"2022","unstructured":"Budin\u00a0CE, Cocuz\u00a0IG, Sab\u0103u\u00a0AH et\u00a0al (2022) Pulmonary Fibrosis Related to Amiodarone-Is It a Standard Pathophysiological Pattern? A Case-Based Literature Review. Diagnostics (Basel) 12(12):3217","journal-title":"Diagnostics (Basel)"},{"key":"5391_CR23","unstructured":"Genovese D, Salama M, Ruggiero D et\u00a0al. (2025) Flecainide in structural heart diseases: A\u00a0contemporary reappraisal beyond the CAST. Heart Rhythm. Published online August\u00a025, 2025."},{"issue":"12","key":"5391_CR24","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJM199103213241201","volume":"324","author":"DS Echt","year":"1991","unstructured":"Echt\u00a0DS, Liebson\u00a0PR, Mitchell\u00a0LB et\u00a0al (1991) Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med 324(12):781\u2013788","journal-title":"N Engl J Med"},{"key":"5391_CR25","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ahj.2016.10.018","volume":"185","author":"SD Pokorney","year":"2017","unstructured":"Pokorney\u00a0SD, Kim\u00a0S, Thomas\u00a0L et\u00a0al (2017) Cardioversion and subsequent quality of life and natural history of atrial fibrillation. Am Heart J 185:59\u201366","journal-title":"Am Heart J"},{"issue":"11","key":"5391_CR26","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jama.2019.0335","volume":"321","author":"C Blomstr\u00f6m-Lundqvist","year":"2019","unstructured":"Blomstr\u00f6m-Lundqvist\u00a0C, Gizurarson\u00a0S, Schwieler\u00a0J et\u00a0al (2019) Effect of Catheter Ablation vs Antiarrhythmic Medication on Quality of Life in Patients With Atrial Fibrillation: The CAPTAF Randomized Clinical Trial. JAMA 321(11):1059\u20131068","journal-title":"JAMA"},{"issue":"5","key":"5391_CR27","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1707855","volume":"378","author":"NF Marrouche","year":"2018","unstructured":"Marrouche\u00a0NF, Brachmann\u00a0J, Andresen\u00a0D et\u00a0al (2018) Catheter Ablation for Atrial Fibrillation with Heart Failure. N Engl J Med 378(5):417\u2013427","journal-title":"N Engl J Med"},{"issue":"22","key":"5391_CR28","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1093\/eurheartj\/ehu001","volume":"35","author":"E Arbelo","year":"2014","unstructured":"Arbelo\u00a0E, Brugada\u00a0J, Hindricks\u00a0G et\u00a0al (2014) The atrial fibrillation ablation pilot study: a European Survey on Methodology and results of catheter ablation for atrial fibrillation conducted by the European Heart Rhythm Association. Eur Heart J 35(22):1466\u20131478","journal-title":"Eur Heart J"},{"issue":"4","key":"5391_CR29","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1001\/jama.2009.2029","volume":"303","author":"DJ Wilber","year":"2010","unstructured":"Wilber\u00a0DJ, Pappone\u00a0C, Neuzil\u00a0P et\u00a0al (2010) Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. JAMA 303(4):333\u2013340","journal-title":"JAMA"},{"issue":"16","key":"5391_CR30","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/j.jacc.2012.11.064","volume":"61","author":"DL Packer","year":"2013","unstructured":"Packer\u00a0DL, Kowal\u00a0RC, Wheelan\u00a0KR et\u00a0al (2013) Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial. J\u00a0Am Coll Cardiol 61(16):1713\u20131723","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"5391_CR31","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jacep.2021.02.014","volume":"7","author":"VY Reddy","year":"2021","unstructured":"Reddy\u00a0VY, Dukkipati\u00a0SR, Neuzil\u00a0P et\u00a0al (2021) Pulsed Field Ablation of Paroxysmal Atrial Fibrillation: 1\u2011Year Outcomes of IMPULSE, PEFCAT, and PEFCAT II. JACC Clin Electrophysiol 7(5):614\u2013627","journal-title":"JACC Clin Electrophysiol"},{"issue":"23","key":"5391_CR32","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1056\/NEJMoa1602014","volume":"374","author":"KH Kuck","year":"2016","unstructured":"Kuck\u00a0KH, Brugada\u00a0J, F\u00fcrnkranz\u00a0A et\u00a0al (2016) Cryoballoon or Radiofrequency Ablation for Paroxysmal Atrial Fibrillation. N Engl J Med 374(23):2235\u20132245. https:\/\/doi.org\/10.1056\/NEJMoa1602014","journal-title":"N Engl J Med"},{"issue":"18","key":"5391_CR33","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1056\/NEJMoa2307291","volume":"389","author":"VY Reddy","year":"2023","unstructured":"Reddy\u00a0VY, Gerstenfeld\u00a0EP, Natale\u00a0A et\u00a0al (2023) Pulsed Field or Conventional Thermal Ablation for Paroxysmal Atrial Fibrillation. N Engl J Med 389(18):1660\u20131671","journal-title":"N Engl J Med"},{"issue":"10","key":"5391_CR34","doi-asserted-by":"crossref","first-page":"e275","DOI":"10.1016\/j.hrthm.2017.05.012","volume":"14","author":"H Calkins","year":"2017","unstructured":"Calkins\u00a0H, Hindricks\u00a0G, Cappato\u00a0R et\u00a0al (2017) 2017 HRS\/EHRA\/ECAS\/APHRS\/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm 14(10):e275\u2013e444","journal-title":"Heart Rhythm"},{"issue":"10","key":"5391_CR35","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1161\/CIRCULATIONAHA.114.014092","volume":"132","author":"VY Reddy","year":"2015","unstructured":"Reddy\u00a0VY, Dukkipati\u00a0SR, Neuzil\u00a0P et\u00a0al (2015) Randomized, Controlled Trial of the Safety and Effectiveness of a Contact Force-Sensing Irrigated Catheter for Ablation of Paroxysmal Atrial Fibrillation: Results of the TactiCath Contact Force Ablation Catheter Study for Atrial Fibrillation (TOCCASTAR) Study. Circulation 132(10):907\u2013915","journal-title":"Circulation"},{"issue":"6","key":"5391_CR36","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.4022\/jafib.1795","volume":"10","author":"M Borlich","year":"2018","unstructured":"Borlich\u00a0M, Iden\u00a0L, Kuhnhardt\u00a0K et\u00a0al (2018) 3D Mapping for PVI- Geometry, Image Integration and Incorporation of Contact Force Into Work Flow. J\u00a0Atr Fibrillation 10(6):1795\u20131795","journal-title":"J Atr Fibrillation"},{"issue":"19","key":"5391_CR37","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1056\/NEJMoa1408288","volume":"372","author":"A Verma","year":"2015","unstructured":"Verma\u00a0A, Jiang\u00a0CY, Betts\u00a0TR et\u00a0al (2015) Approaches to catheter ablation for persistent atrial fibrillation. N Engl J Med 372(19):1812\u20131822","journal-title":"N Engl J Med"},{"issue":"24","key":"5391_CR38","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1016\/j.jacc.2015.09.088","volume":"66","author":"J Vogler","year":"2015","unstructured":"Vogler\u00a0J, Willems\u00a0S, Sultan\u00a0A et\u00a0al (2015) Pulmonary Vein Isolation Versus Defragmentation: The CHASE-AF Clinical Trial. J\u00a0Am Coll Cardiol 66(24):2743\u20132752","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"5391_CR39","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1080\/14779072.2025.2569402","volume":"23","author":"E Zito","year":"2025","unstructured":"Zito\u00a0E, La Fazia\u00a0VM, Gianni\u00a0C et\u00a0al (2025) Alternative options to thermal ablation for atrial fibrillation: the role of pulsed field ablation in reducing complications and maintaining efficacy. Expert Rev Cardiovasc Ther 23(11):675\u2013692","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"3","key":"5391_CR40","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/joa3.12710","volume":"38","author":"RM Ronsoni","year":"2022","unstructured":"Ronsoni\u00a0RM, Silvestrini\u00a0TL, Saffi\u00a0MAL et\u00a0al (2022) Impact of the left common ostium following pulmonary vein isolation in AF: Systematic review and meta-analysis. J\u00a0Arrhythm 38(3):287\u2013298","journal-title":"J Arrhythm"},{"issue":"4","key":"5391_CR41","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.4022\/jafib.1620","volume":"10","author":"U Canpolat","year":"2017","unstructured":"Canpolat\u00a0U, Kocyigit\u00a0D, Aytemir\u00a0K (2017) Complications of Atrial Fibrillation Cryoablation. J\u00a0Atr Fibrillation 10(4):1620","journal-title":"J Atr Fibrillation"},{"issue":"4","key":"5391_CR42","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1093\/europace\/euu320","volume":"17","author":"A F\u00fcrnkranz","year":"2015","unstructured":"F\u00fcrnkranz\u00a0A, Bordignon\u00a0S, Schmidt\u00a0B et\u00a0al (2015) Incidence and characteristics of phrenic nerve palsy following pulmonary vein isolation with the second-generation as compared with the first-generation cryoballoon in 360 consecutive patients. Europace 17(4):574\u2013578","journal-title":"Europace"},{"issue":"18","key":"5391_CR43","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1056\/NEJMoa2307291","volume":"389","author":"VY Reddy","year":"2023","unstructured":"Reddy\u00a0VY, Gerstenfeld\u00a0EP, Natale\u00a0A et\u00a0al (2023) Pulsed Field or Conventional Thermal Ablation for Paroxysmal Atrial Fibrillation. N Engl J Med 389(18):1660\u20131671","journal-title":"N Engl J Med"},{"issue":"19","key":"5391_CR44","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1161\/CIRCULATIONAHA.123.063988","volume":"147","author":"A Verma","year":"2023","unstructured":"Verma\u00a0A, Haines\u00a0DE, Boersma\u00a0LV et\u00a0al (2023) Pulsed Field Ablation for the Treatment of Atrial Fibrillation: PULSED AF Pivotal Trial. Circulation 147(19):1422\u20131432","journal-title":"Circulation"},{"issue":"24","key":"5391_CR45","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1161\/CIRCULATIONAHA.122.061497","volume":"146","author":"VY Reddy","year":"2022","unstructured":"Reddy\u00a0VY, Petru\u00a0J, Funasako\u00a0M et\u00a0al (2022) Coronary Arterial Spasm During Pulsed Field Ablation to Treat Atrial Fibrillation. Circulation 146(24):1808\u20131819","journal-title":"Circulation"},{"key":"5391_CR46","doi-asserted-by":"publisher","DOI":"10.1111\/pace.70238","author":"NB Spath","year":"2026","unstructured":"Spath\u00a0NB, Das\u00a0M (2026) Transient Atrioventricular Block With Focal Pulsed Field Ablation. Pacing Clin Electrophysiol. https:\/\/doi.org\/10.1111\/pace.70238","journal-title":"Pacing Clin Electrophysiol"},{"issue":"3","key":"5391_CR47","volume":"18","author":"MH Ohn","year":"2025","unstructured":"Ohn\u00a0MH, Mukherjee\u00a0R, Saba\u00a0M (2025) Transient conduction disturbance during pulsed-field ablation for atrial fibrillation in a patient with pre-existing conduction disease. BMJ Case Rep 18(3):e263763","journal-title":"BMJ Case Rep"},{"issue":"8","key":"5391_CR48","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1038\/s41591-024-03022-6","volume":"30","author":"E Anter","year":"2024","unstructured":"Anter\u00a0E, Mansour\u00a0M, Nair\u00a0DG et\u00a0al (2024) Dual-energy lattice-tip ablation system for persistent atrial fibrillation: a randomized trial. Nat Med 30(8):2303\u20132310","journal-title":"Nat Med"},{"key":"5391_CR49","doi-asserted-by":"crossref","unstructured":"Watfa A, Younis A, Mdaihly M et\u00a0al. (2025) Safety of Same-Day Discharge Following Pulsed-Field Ablation Versus Radiofrequency Ablation: A\u00a0Comparative Analysis. Pacing Clin Electrophysiol.;48(8):852\u2013858.","DOI":"10.1111\/pace.70005"}],"container-title":["Herz"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-026-05391-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00059-026-05391-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-026-05391-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:29:00Z","timestamp":1792092540000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00059-026-05391-9"}},"subtitle":["Ein \u00dcberblick \u00fcber die verschiedenen Behandlungsoptionen","An overview of the various treatment options"],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["5391"],"URL":"https:\/\/doi.org\/10.1007\/s00059-026-05391-9","relation":{},"ISSN":["0340-9937","1615-6692"],"issn-type":[{"value":"0340-9937","type":"print"},{"value":"1615-6692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,24]]},"assertion":[{"value":"22 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autorinnen und Autoren sowie die Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":1,"name":"Ethics","label":"Interessenkonflikt","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"L.\u00a0Fischbach\n                      : Es liegen keine Interessenkonflikte vor.\n                      S.\u00a0Willems\n                      : Abbott, Medtronic, Boston Scientific, BMS, Johnson&Johnson, Boehringer Ingelheim, Biotronik Educational Grants: Abbott, Johnson&Johnson, Boston Scientific.\n                      A.\u00a0Sultan\n                      : Educational Grants and Honoraria: Abbott, Medtronic, Johnson&Johnson, Pfizer, Boston Scientific, BMS.","order":2,"name":"Ethics","label":"Autorinnen und Autoren","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf\n                      \n                      .","order":3,"name":"Ethics","label":"Wissenschaftliche Leitung","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":4,"name":"Ethics","label":"Der Verlag","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}}]}}